Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Mobile app training to strengthen control over food

Official title: Testing FoodTraining (FoodT): A Mobile App to Train Inhibitory Control Towards Food and Augment Standard Treatment for People With Eating and Weight Disorders

Run by University of Padova · NCT07075952 · Data updated 2026-11-12

This project tests whether a four-week mobile app (FoodTraining) can strengthen food-related self-control for people with obesity, binge-eating disorder, or bulimia who are receiving usual outpatient care.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment113 (estimated)
SponsorUniversity of Padova
Academic / other
Locations1 site (Padova, Padova)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMarch 2026
Study endsMarch 2027
Registry record updatedDecember 30, 2025
Trial IDNCT07075952 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People with obesity (BMI > 30) or a clinician-diagnosed binge-eating disorder or bulimia nervosa who speak Italian or English and have access to a smartphone or tablet are ideal candidates.

Probably not a fit

Patients with untreated psychosis, intellectual disability, uncorrected visual impairment, or those without a compatible mobile device may not be suitable and are unlikely to benefit from this app-based intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional project will enroll 113 participants with obesity, binge-eating disorder, or bulimia nervosa and offer a food-specific inhibitory control training via the FoodTraining app in addition to treatment as usual (TAU), compared with TAU alone. Participants complete questionnaires at baseline, 4 and 8 weeks measuring eating behaviour, eating-disorder symptoms, mood, social functioning and quality of life. They will also use the FoodTracker app for ecological momentary assessments of intake, thoughts and emotions, and wear non-invasive sensors for glucose monitoring. The trial focuses on feasibility, acceptability, adherence, and clinical impact on emotional and uncontrolled eating.

Why it matters

Potential benefit: If successful, the app could provide an easy-to-access adjunct that helps reduce overeating and improves self-control around food when used alongside usual treatment.

How similar studies have gone: Prior laboratory and small clinical studies of inhibitory-control trainings have shown mixed but sometimes modest reductions in food intake or binge episodes, while delivering this approach via a mobile app remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI in the obesity range (\>30) or a clinician-formulated diagnosis of binge eating disorder or bulimia nervosa;
* knowledge of Italian or English;
* access to a mobile device (e.g. smartphone, tablet).

Exclusion Criteria:

* visual impairment not corrected by glasses
* a diagnosis of psychosis;
* intellectual disability.

Where it's running

  • Psychiatry Unit, University Hospital, Padova and Bariatric Unit, University Hospital, Padova
    Padova, Padova, Italy
    Recruiting

Study contacts

  • Principal investigator: Valentina Cardi, PhD — Department of General Psychology, University of Padova, Padova, Italy
  • Study coordinator: Valentina Cardi, PhD
  • Email: valentina.cardi@unipd.it
  • Phone: +39049827

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.